Key result
Autoimmune chronic inflammatory disease was associated with a higher risk of 30-day all-cause mortality in patients undergoing aortic valve replacement.
Why the study?
Patients with autoimmune chronic inflammatory disease are at increased risk of valvular heart disease, but the impact of CID on surgical or transcatheter AVR prognosis remains unclear.
Does the presence of autoimmune chronic inflammatory disease increase adverse clinical outcomes in patients undergoing aortic valve replacement?
Meta-Analysis (n=572,351)
Does the presence of autoimmune chronic inflammatory disease increase adverse clinical outcomes in patients undergoing aortic valve replacement?
Patients with chronic inflammatory diseases undergoing aortic valve replacement face a significantly higher risk of 30-day mortality and in-hospital infections compared to patients without these conditions.
Answers are grounded in this paper and cite their sources.
Chronic inflammatory disease may raise short-term mortality and infection risk after aortic valve replacement; leaves open need for targeted mitigation strategies.
Patients with autoimmune chronic inflammatory disease (CID) are at an increased risk of valvular heart disease, including aortic valve stenosis, insufficiency, or both. The impact of CID on the prognosis of surgical or transcatheter aortic valve replacement (AVR) remains unclear. This meta-analysis aims to evaluate the impact of CID on major clinical outcomes in this population. A comprehensive literature search of PubMed, Cochrane, and Embase databases was conducted to identify relevant studies. The primary endpoint was 30-day all-cause mortality between patients with CID and controls. Secondary endpoints included, long-term all-cause mortality, stroke and in-hospital infection. Statistical analysis included Risk Ratio (RR) with 95% confidence interval (CI) using the random-effects model. Five studies involving 572,351 patients were included in the meta-analysis. Patients with CID had a greater 30-day mortality (RR = 1.17, 95% CI: 1.09, 1.27; P < .001) and a higher rate of in-hospital infection (RR = 2.13, 95% CI: 1.03, 4.41; P < .001). No differences were observed in the other secondary endpoints. Patients with CID are at an increased risk of short-term all-cause mortality and in-hospital infections after AVR. Further studies are required to validate our results and define the optimal management of these patients.
No takes yet. Share an insight, caveat, or question.
Theodoropoulou et al. (2025) conducted a meta-analysis in Aortic Valve Replacement (n=572,351). Autoimmune chronic inflammatory disease (CID) vs. Controls (without CID) was evaluated on 30-day all-cause mortality (RR 1.17, 95% CI 1.09, 1.27, p=< .001). Autoimmune chronic inflammatory disease was associated with a higher risk of 30-day all-cause mortality in patients undergoing aortic valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: